BOLT vs MSFT: Which Stock is Better?
Side-by-side comparison of Bolt Biotherapeutics and Microsoft Corporation in 2026
BOLT
Bolt Biotherapeutics
$4.07
MSFT
Microsoft Corporation
$499.32
Key Metrics Comparison
| Metric | BOLT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $11.33M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | BOLT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 90.1% | 18.4% | BOLT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze BOLT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BOLT or MSFT a better investment?
Comparing BOLT and MSFT: Bolt Biotherapeutics has a market cap of $11.33M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BOLT and MSFT?
BOLT (Bolt Biotherapeutics) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BOLT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BOLT or MSFT?
BOLT has higher revenue growth at 90.1% vs 18.4% for MSFT.
Which company is more profitable: BOLT or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for BOLT.
Which is the larger company: BOLT or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $11.33M for BOLT.
Should I buy BOLT or MSFT in 2026?
Both BOLT and MSFT have investment merit. BOLT trades at $4.07 while MSFT trades at $499.32. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BOLT and MSFT stock?
Key differences: Market Cap ($11.33M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (90.1% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy BOLT or MSFT in 2026?
The choice between BOLT and MSFT depends on your investment goals. BOLT shows higher revenue growth (90.1%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between BOLT and MSFT?
BOLT (Bolt Biotherapeutics) has a market cap of $11.33M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.